Navigation Links
BioSpecifics Technologies Corp. Announces Top-line Data from Phase 2 Trial of CCH for Canine Lipoma
Date:12/23/2013

LYNBROOK, N.Y., Dec. 23, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced top-line data from Chien-804, the placebo-controlled, double-blind, randomized Phase 2 trial evaluating the efficacy of collagenase clostridium histolyticum (CCH) in canines with benign subcutaneous lipomas. Lipomas are encapsulated deposits of fat often detected as bulges under the skin and affect an estimated 1.7 million dogs in the U.S. The trial did not meet its primary endpoint of a statistically significant post-treatment difference in the mean percent change in lipoma volume by CT scan; however, in the responder analysis there was a statistically significant reduction in lipoma surface area among dogs treated with CCH (p=0.0084).

"We are disappointed that the study did not meet its primary endpoint but are pleased that we achieved statistical significance in a responder analysis of those dogs who had a 50% decrease in lipoma surface area as measured by caliper, which is a standard method for measuring a subcutaneous lipoma," commented Thomas L. Wegman, President of BioSpecifics. "We are also encouraged to see a high satisfaction rating from the owners of pets who received CCH and hope to be able to offer them this minimally-invasive treatment."

Chien-804 enrolled 37 dogs in a single injection study randomized 1:1 CCH to placebo with lipoma volume being measured by CT scan and lipoma surface area being measured by caliper at baseline, one month and 90 days. The data at 90 days show a post-treatment difference in the mean percent change in lipoma volume by CT scan between the CCH and placebo-treated groups of -11.58% (p=0.52), whic
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
2. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
3. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
4. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
5. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
6. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
8. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2013 Financial Results on Tuesday, November 12, 2013
9. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
10. UV Flu Technologies Expands Its International Footprint
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... manufacturer and supplier, announces the launch of their 2nd generation cell therapy POD® ... current miniPOD CT, but it also represents a new POD® design. , ...
(Date:7/29/2015)... 29, 2015  Therapath Neuropathology ( www.Therapath.com ), ... with VA and Military Medical centers both domestically ... (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD) ... https://therapath.com/skin ). Demonstration of a ... on punch skin biopsy is a highly sensitive ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company, is pleased to announce that ... injector (RCI-02) have been locked.  Prototypes for industrial ... prepare for an application for CE mark clearance ... in 2016. (Photo: ...
(Date:7/29/2015)... FRANCE (PRWEB) , ... July 29, 2015 , ... ... Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel, a nighttime-specific product that ... the amount of sugars that are able to enter fat cells, inhibiting the ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3Neuropathology services for VA and Military health systems 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3
... (Nasdaq: BMRN ) today announced that Dr. Emil Kakkis, ... 2009. Dr. Kakkis has,decided to leave his position with the ... time to personal endeavors related to rare diseases. Dr.,Kakkis will ... , "I am extremely grateful ...
... Nov. 21 MichBio, the association for,Michigan,s biosciences ... to its fourth annual Expo on Tuesday and ... in Novi, MI. The MichBio Expo is,the ... addition, this year,s event attracted 56 exhibitors. The ...
... Lilly and,Company (NYSE: LLY ) and ImClone Systems ... of the previously announced tender offer,by Lilly,s wholly-owned subsidiary, Alaska ... of $70.00 per share in cash. The,offer expired at ... The depositary for the tender ...
Cached Biology Technology:BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 2BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 3BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 4MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 3Lilly Completes Cash Tender Offer for ImClone Systems 2Lilly Completes Cash Tender Offer for ImClone Systems 3
(Date:7/20/2015)... 2015  Acuity Market Intelligence,s latest research "The ... Commerce and Privacy" forecasts that between 2014 and ... be downloaded to smart mobile devices by 2.2 ... is projected to generate more than $67.9 billion ... forecast period.    "Biometrics is at ...
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... Society (ACS) News Service Weekly PressPac with news from ... credit the individual journal or the American Chemical Society ... ARTICLE #1 FOR IMMEDIATE RELEASE , Hyped-up hopes for ... reporting an advance towards tapping the immense potential of ...
... biomedical researchers from the USC Viterbi School, the College and ... $6-million Bioengineering Research Partnership grant from the National Institutes of ... older adults who suffer from significant vision loss. ... Norberto Grzywacz, professor of biomedical engineering in the Viterbi School ...
... California, Irvine scientists have discovered how to reverse the ... form of mental impairment. Neurobiologist Julie Lauterborn and ... fragile X syndrome blocks brain cells from locking new ... X mental retardation 1 (Fmr1) -- is turned off ...
Cached Biology News:American Chemical Society's Weekly PressPac -- Oct. 3, 2007 2American Chemical Society's Weekly PressPac -- Oct. 3, 2007 3American Chemical Society's Weekly PressPac -- Oct. 3, 2007 4American Chemical Society's Weekly PressPac -- Oct. 3, 2007 5American Chemical Society's Weekly PressPac -- Oct. 3, 2007 6American Chemical Society's Weekly PressPac -- Oct. 3, 2007 7American Chemical Society's Weekly PressPac -- Oct. 3, 2007 8USC biomedical team to participate in $6 million low vision project 2USC biomedical team to participate in $6 million low vision project 3USC biomedical team to participate in $6 million low vision project 4UCI researchers restore memory process in most common form of mental disability 2
... 2 Block MBS Start up kit. ... software and choice of 2 MultiBlock ... to 30 blocks. User friendly software. ... Adjustable height heated lid. Outstanding ...
... drives of VARIOMAG Magnetic Stirrers operate without ... or mechanical bearings, making VARIOMAG Magnetic Stirrers ... VARIOMAG inductive drive can be hermetically sealed, ... microorganisms. This is why VARIOMAG Magnetic Stirrers ...
... Enzymatic method stops PCR carry-over contamination, ... to degrade PCR products from previous ... acid templates, which improves amplification ,Optimized ... reagents and GeneAmp instrument systems , ...
... Class II safety cabinets Heraeus HERAsafe KS convince ... design. ,The new frameless slanted window does ... The new front window design makes it easy ... work aperture with a height of more than ...
Biology Products: